用户名: 密码: 验证码:
DNA错配修复蛋白缺失与结直肠癌临床病理相关性及预后研究
详细信息    查看官网全文
摘要
目的:研究DNA错配修复蛋白缺失与结直肠癌临床病理相关性及预后。方法:利用免疫组织化学及HE染色,观察结直肠增生性息肉,腺瘤,伴高级别上皮内瘤变腺瘤,结直肠癌病变组织中MLHl、MSH2、MSH6、PMS2、P53、Ki-67蛋白的表达情况。结果:在结直肠癌中,MSI(MSI-H)占13.9%,MSS肿瘤占86.1%。MSI(MSI-H)与结直肠癌所在部位,肿瘤类型,肿瘤分化程度,肿瘤ki-67增殖指数相关,具有统计学意义;与p53蛋白表达无统计学意义。结论:MSI(MSI-H)主要分布在右半结肠,低分化腺癌,粘液性腺癌,具有高增殖指数的癌组织中。它能够评估结直肠癌的预后,成为林奇综合征的基因诊断标志物。
Purpose The study of defective DNA mismatch repair protein and colorectal cancer clinical pathological correlation and prognosis. Methods Using immunohistochemistry and HE staining to observe MLHl, MSH2 and MSH6 and PMS2, p53, Ki-67 protein expression in colorectal hyperplastic polyps, adenoma, with high grade intraepithelial neoplasia adenoma and colorectal cancer lesions. Results In colorectal cancer, MSI(MSI-H) accounted for 13.9%, MSS accounted for 86.1%. MSI(MSI-H) have statistical significance with colorectal cancer location, tumor type, tumor differentiation, tumor Ki-67 proliferation index,and have statistical significance and no statistical significance with e p53 protein. Conclusion MSI(MSI-H) is mainly distributed in the right colon, poorly differentiated adenocarcinoma, mucinous adenocarcinoma and high proliferation index of carcinoma. It can evaluate the prognosis of colorectal cancer, be a markers of genetic diagnosis in Lynch syndrome.
引文
[1]陈万青,张思维,郑荣寿等.中国肿瘤登记地区2007年肿瘤发病和死亡分析[J].中国肿瘤,2011,20(3):1.62-169.
    [2]Cunningham D,Atkin W,Lenz HJ et al.Colorectal cancer[J].Lancet,2010,375(9719):1030-1047.
    [3]Boland CR Goel A.Microsatellite instability in colorectal cancer[J].Gastroenterology,2010,36(6):2073-2087.
    [4]Jass JR.Classification of colorectal cancer based on correlation of clinical,morphological and molecular features[J].Histopathology,2001,50:113-130.
    [5]Hemminki K,Eng C.Clinical genetic counseling for familial cancers requires reliable date on familial cancer risks and gene reaction plants[J].J med genet,2004,41(11):8701-807.
    [6]支文雪,石素胜.微卫星不稳定性在结直肠癌中的意义[J].国际肿瘤学杂志2012(39)12:935-938.
    [7]Pino MS,Chung DC.Micmsatellite instability in the management of colorectal cancer.Expert Rev Gastroenteml.Hepatol,201 1,5(3):385-399.
    [8]Boland CR,Thibodeau SN,Hamilton SR,et a1.A National Cancer Institute Workshop on Micmsatellite Instability for cancer detection and familial predisposition:development of international criteria for the determination of microsatellite instability in colorectal cancer[J].Cancer Res,1998,58(22):5248-5257.
    [9]Umar A,Boland CR,Terdiman JP,et a1.Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer(Lynch syndrome)and microsatellite instability[J].J Natl Cancer Inst,2004,96(4):261-268.
    [10]Poulogiannis G,Frayling IM,Arends MJ.DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.Histopathology,2010,56(2):167-179
    [11]Lanza G,Gafa R,Santini A,et al.Immunohistochemical test for MLH1 and MLH2 expression predicts clinical outcome in stage II and III colorectal cancer patients[J].J Clinical,2006,24(15):2359-2367.
    [12]石雪,迎郑杰.系统筛查微卫星不稳定性结直肠癌的意义和策略[J].中华病理学杂志2015.44(1):9-13.
    [13]Fearon ER,Vogelstein B.A genetic model for colorectal tumor genesis.Cell 1990;61:759-767
    [14]Park IJ,Kim HC,Kim JS,Yu ES,Yu CS,Kim JC.Correlation between h MLH1/h MSH2 and p53 protein expression in sporadic colorectal cancer.Hepatogastroenterology 2005;52:450-454
    [15]Sibel Erdamar,Esra Ucaryilmaz,Gokhan Demir.etl.Importance of Mut L homologue MLH1 and Mut S homologue MSH2 expression in Turkish patients with sporadic colorectal cancer World J Gastroenterology 2007 September 7;13(33):4437-4444.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700